1. Protein Tyrosine Kinase/RTK Immunology/Inflammation GPCR/G Protein
  2. FLT3 Interleukin Related CCR
  3. Flt-3L-Ig (hum/hum)

Flt-3L-Ig (hum/hum)  (Synonyms: human Flt3L; hFlt3L)

Cat. No.: HY-P991208 Purity: 98%
Technical Support

Flt-3L-Ig (hum/hum) (hFlt3L) is a Flt3 ligand. Flt-3L-Ig (hum/hum) enhances the release of inflammatory cytokines from myeloid cells and dendritic cells in BRGSF-CBC mice induced by OKT3. Flt-3L-Ig (hum/hum) increases the release of IL-2, CCL2 and CXCL10 in an OKT3-dependent manner. Flt-3L-Ig (hum/hum) can be used in studies related to cytokine release syndrome. Flt-3L-Ig (hum/hum) can be used in studies related to psoriasis-like skin inflammation.

For research use only. We do not sell to patients.

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Flt-3L-Ig (hum/hum) (hFlt3L) is a Flt3 ligand. Flt-3L-Ig (hum/hum) enhances the release of inflammatory cytokines from myeloid cells and dendritic cells in BRGSF-CBC mice induced by OKT3. Flt-3L-Ig (hum/hum) increases the release of IL-2, CCL2 and CXCL10 in an OKT3-dependent manner. Flt-3L-Ig (hum/hum) can be used in studies related to cytokine release syndrome. Flt-3L-Ig (hum/hum) can be used in studies related to psoriasis-like skin inflammation[1][2].

IC50 & Target[1]

IL-2

 

In Vivo

Flt-3L-Ig (hum/hum) (10 μg per injection; i.p.; four times every 2-3 days) boosts human myeloid and dendritic cell compartments in BRGSF-CBC mice, significantly enhancing multiple OKT3-induced CRS features including cytokine release, body weight loss, temperature reduction, immune cell depletion, and immune cell activation[1].
Flt-3L-Ig (hum/hum) (10 μg; i.p.; on day 0, 2, 4, and 7) increases immune cell populations in BRGSF-HIS mice[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BRGSF mice (female, 21-22 weeks old, humanized with umbilical cord blood CD34+ cells)[1]
Dosage: 10 μg per injection
Administration: i.p.; four times on days 0, 2, 4, and 7 (every 2-3 days)
Result: Increased OKT3-induced serum levels of IL-2, CCL2, and CXCL10.
Enhanced OKT3-induced body weight loss, reaching a 13-15% reduction from baseline at 48h post-OKT3.
Induced a significant temperature drop, a ~4-6% reduction from baseline at 24h post-OKT3, an effect not seen in non-boosted mice.
Amplified OKT3-induced depletion of plasmacytoid dendritic cells (pDCs), conventional dendritic cells (cDCs), and monocytes/macrophages.
Enhanced OKT3-induced activation of pDCs, cDCs, and neutrophils, measured by increased percentages of CD86+, CD80+, and CD86+/CD80+ cells in these populations.
Increased absolute and relative numbers of human monocytes/macrophages, pDCs, and cDCs in bone marrow, spleen, and systemic circulation without inducing significant immune cell activation.\nEnabled detection of Blinatumomab-induced CRS features, including significant increases in serum levels of human TNF-α, IL-6, IFN-γ, CCL2, and CXCL10, and a sustained, significant reduction in body temperature at the 5 μg/kg Blinatumomab dose.\nEnabled detection of JNJ-induced CRS features, including dose-dependent increases in serum levels of human CCL5, CCL2, CXCL8, TNF-α, IL-1RA, and IL-10.
Caused significant depletion of monocytes/macrophages and cDCs at 48h post-JNJ injection.
Induced significant increases in the percentage of CD86+ activated monocytes/macrophages and cDCs at 24h post-JNJ injection (at the 20 mg/kg JNJ dose).
Application

ELISA, FACS, Functional assay

Conjugated

Unconjugated

Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.

Molecular Weight

86.938 kDa

Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Flt-3L-Ig (hum/hum)]

Shipping

Shipping with dry ice.

Formulation

Please refer to the lot-specific COA for specific buffer information.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Biological Activity
  • Loaded Flt-3L-Ig (hum/hum) on AHC2 biosensor, can bind FLT3 Protein, Human (T227M, HEK293, His, HY-P75183) with an affinity constant of 2.041E-08 M as determined in BLI assay.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Flt-3L-Ig (hum/hum)
Cat. No.:
HY-P991208
Quantity:
MCE Japan Authorized Agent: